2m 2m 2m 2m 2m 2m 2m
Dexcom (DXCM)
NASDAQ
$80.95+$0.61 (+0.76%)
Price as of Nov 12, 2026 9:06 AM EST- $30.0BMarket Cap
- 34.78%1-Year Change
- Medical DevicesIndustry
Dexcom (DXCM)
$80.95+$0.61 (+0.76%)
DXCM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $80.34 | ||
Change | +$0.42 (+0.53%) | ||
Open | $79.80 | ||
High | $80.58 | ||
Low | $78.93 | ||
Previous Close | $79.92 | ||
Volume | 3,231,221 | ||
30-Day Average Volume | 4,869,519 | ||
1-Week Change | -9.19% | ||
1-Month Change | -4.48% | ||
1-Year Change | 34.78% | ||
3-Year Change | -14.57% | ||
5-Year Change | -49.58% | ||
Fundamentals | |||
Shares Outstanding | 373.0M | ||
Total Assets | $6.2B | ||
Market Cap | $30.0B | ||
Enterprise Value | $30.2B | ||
Period: QTR TTM FY | |||
Revenue | $1.3B | ||
Net Income | $275.1M | ||
Free Cash Flow | $272.7M | ||
EBIT | $336.8M | ||
EBITDA | $411.3M | ||
Net Working Capital | $1.7B | ||
EPS | $0.72 | ||
Enterprise Value/EBITDA | 74 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 12 | ||
P/E | 112 | ||
PEG | 9 | ||
Price/Free Cash Flow | 110 | ||
Price/Operating Cash Flow | 92 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 4 : 1 | ||
Last Split Date | 06/13/2022 | ||
Earnings & Revenue